A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Clinical trial NCT05337735 · SUSPENDED

Trial details

NCT number: NCT05337735
Sponsor: M.D. Anderson Cancer Center
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Microsatellite High Cancers Peritoneal Mesothelioma Extrapulmonary High Grade Neuroendocrine Carcinomas Cervical Carcinoma Hodgkin's Lymphoma Pleural Mesothelioma Small Cell Lung Cancer

Start date: 2022-08-05
Primary completion: 2026-12-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.